Mexico puts US$46m into HIV/STI centres plan
This article was originally published in Clinica
Mexico has announced plans to invest M$500m (US$46.4m) in 51 ambulatory HIV and sexually-transmitted infection (STI) care and prevention centres. The aim of the CAPASITS (Centro Ambulatorio de Prevencion y Atencion en VIH/SIDA e Infecciones de Transmision Sexual) network is to provide widespread access to HIV/STI services, as well as free treatment for the around 20,000 (of around 180,000) HIV patients who are not insured under Mexico's IMSS, ISSSTE or other social insurance programmes.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.